Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Associate

Biotechnology · India · 2025-06-07

Processing Time
30 days
Decision Date
2025-06-07
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop and apply advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. The work specifically focuses on chronic diseases such as HIV and Epstein-Barr Virus (EBV) to advance therapeutic strategies and vaccine development. This research aims to lower disease burdens and improve public health outcomes by addressing infectious disease control.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical healthcare challenges and national priorities in biotechnology and infectious disease control.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 8 publications, 174 citations, and 12 peer reviews demonstrates a high level of expertise and influence in the field.

3 Waiver of Job Offer and Labor Certification Met

The potential for the research to lower disease burdens and improve public health outcomes makes it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 8 peer-reviewed journal articles, 2 abstracts, and 1 preprint, which accumulated 174 citations. One article was noted for being in the top 20% of most-cited papers in its field, and the petitioner completed 12 peer reviews. The case was supported by funding from the NIH, NIAID, and Moderna, Inc., satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 5 days 2024-07-30
The petitioner proposes to continue researching viral pathogenesis and host-virus interactions to unravel the mechanisms of viral replication, transmission, and pathogenesis. This work aims to design vaccines, antiviral drugs, and diagnostic tools to combat viral threats and mitigate pandemics.
View Case

Postdoctoral Researcher

Biotechnology

WeGreened EB-2 (NIW) approved
Texas 26 days 2025-02-05
The petitioner proposes to continue investigating the molecular dynamics of viral replication and pathogenesis using model viral systems at a U.S. academic institution. This work focuses on exploring viral-host interactions and immune evasion strategies to facilitate the development of advanced vaccine platforms and targeted antiviral therapies. The endeavor aims to strengthen the United States' defense against viral epidemics and bioterrorism threats.
View Case

Postdoctoral Researcher

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) approved
Tennessee 64 days 2025-03-13
The petitioner proposes to advance innovative immunization strategies and translational studies aimed at developing effective vaccines and therapeutics targeting infectious pathogens. The work focuses on investigating host-pathogen interactions and the underlying mechanisms of protective immune responses to strengthen public health systems.
View Case

Research Fellow

Biotechnology · Estonia

WeGreened EB-2 (NIW) approved
Maryland 36 days 2025-05-09
The petitioner proposes to continue her research in the field of biomedical sciences, specifically focusing on the development and characterization of antiviral therapeutics. She utilizes advanced molecular virology, multi-omics, and immune profiling techniques to unravel complex virus-host interactions. Her work aims to inform the creation of novel treatment approaches and improve existing virus mitigation strategies to enhance public health resilience.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 30 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist